Papers

2

Total Citations

26

H-Index

2

About

Xu‐Feng Zhang is a leading figure in the advancement of liver transplantation, with a focused expertise in telemedicine, minimally invasive surgery, and post-transplant patient management. His major contributions include pioneering the use of telemedicine for follow-up care in liver transplant recipients, as demonstrated by his 2021 cohort study (24 citations), which addresses the critical challenge of managing patients after surgery, particularly when utilizing marginal donor grafts. Dr. Zhang also co-authored the landmark "Chinese guidelines for minimally invasive surgery in liver transplant recipients (2025)" (2 citations), a seminal work that establishes standardized protocols for laparoscopy and robotic surgery in this complex patient population. This guideline reflects his role in shaping national clinical practice and reducing surgical trauma. With a career dedicated to improving outcomes in end-stage liver disease, Dr. Zhang’s work has had a tangible impact on both surgical technique and long-term patient care, bridging innovation with practical, patient-centered solutions.

Research Focus

Key Achievements

2
H-Index
2
Papers
26
Total Citations
13
Avg Citations/Paper
🏆 Most Cited Paper
Telemedicine for Follow-up Management of Patients After Liver Transplantation: Cohort Study
24 citations · 2021
📈 Most Prolific Year: 2021 (1 Papers)
🤝 Key Collaborators: 32
🏛 Institutions: First Affiliated Hospital of Xi'an Jiaotong University

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago